🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Start Date
2007-11-19
Trial ID
NCT00720304
Treatments Being Tested
Determine whether viagenpumatucel-L combined with low-dose cyclophosphamide...
Status
Terminated
Location
Highlands Oncology Group
Start Date
2014-07
Trial ID
NCT02117024
Study Rationale: There is increasing evidence that erlotinib improves over...
Status
Completed
Location
Meir Medical Center
Start Date
2009-02
Trial ID
NCT00840125
This 2 arms study will compare the efficacy and safety of treatment with se...
Status
Completed
Location
Service de Pneumologie, CHU Angers
Start Date
2011-06
Trial ID
NCT01350817
Treatments Being Tested
This Phase II, multicenter, randomized trial is designed to make preliminar...
Status
Completed
Location
Comprehensive Blood and Cancer Center (TORI)
Start Date
2004-07
Trial ID
NCT00095225
Treatments Being Tested
Background: Advanced urothelial cancer has no cure. But only a few chemoth...
Status
Completed
Location
National Institutes of Health Clinical Center
Start Date
2017-03-27
Trial ID
NCT02788201
Treatments Being Tested
This is a Phase Ib/II, open-label, single institution dose-escalation, safe...
Status
Terminated
Location
University of Texas Health Science Center at San Antonio
Start Date
2024-12-27
Trial ID
NCT06516887
Treatments Being Tested
This was an open-label, multicenter, single-arm, Phase II trial of bevacizu...
Status
Completed
Location
Multiple Locations
Start Date
2006-03
Trial ID
NCT00312728
Treatments Being Tested
The goal of this clinical research study is to find the highest safe dose o...
Status
Completed
Location
UT MD Anderson Cancer Center
Start Date
2005-04
Trial ID
NCT00113347
Treatments Being Tested
RATIONALE: Studying the proteins expressed in samples of blood and tissue f...
Status
Unknown
Location
Istituto Scientifico H. San Raffaele
Start Date
2008-02
Trial ID
NCT00989690